Pilgrim Partners Asia’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$205K Sell
3,000
-3,600
-55% -$294K 0.19% 30
2024
Q4
$513K Buy
+6,600
New +$489K 0.45% 30

Other funds holding DXCM

Pilgrim Partners Asia's DXCM Position: Q1 2025 in Review

Pilgrim Partners Asia reduced its DexCom (DXCM) stake by 55% in Q1 2025, selling an estimated $294K and leaving 3,000 shares worth $205K. The position accounts for 0.19% of the portfolio, ranked #30.

Pilgrim Partners Asia first reported a position in DXCM in Q4 2024 and has held it in 2 quarters since. The position peaked at $513K in Q4 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Pilgrim Partners Asia held 3,000 shares of DexCom worth $205K as of Q1 2025.
  • Pilgrim Partners Asia sold 3,600 DexCom shares in Q1 2025, an estimated $294K.
  • DexCom made up 0.19% of Pilgrim Partners Asia's portfolio in Q1 2025, its #30 holding.
  • Pilgrim Partners Asia first reported a position in DexCom in Q4 2024 and has held it in 2 quarters since.
  • Pilgrim Partners Asia's DexCom position peaked at $513K in Q4 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Pilgrim Partners Asia's 13F filing for Q1 2025, filed 14 May 2025.